Physiologas, an IGE Global Innovation - Beyond Japan alum, raises funds with Lotte Holdings CVC as lead investor.

Series A round (first close) accelerates product development aimed at the social implementation of home hemodialysis, which improves the quality of life of end-stage renal disease patients and their families. Managing Director, Kazuyoshi (KAZ) Miyawaki, and COO Kazuyoshi Tatemoto, participated in the IGE 2023 Beyond Japan cohort sponsored by the Japan External Trade Organization - Los Angeles (Jetro LA). 

Beyond Japan Zero to X is a program designed to nurture entrepreneurs and leaders who will drive the next generation of innovation and contribute to Japan's growth strategy. This program provides personalized assistance and training specifically tailored to participants' grasp of startup phases and the North American business landscape. It aims to empower participants to take proactive steps and optimize their effectiveness.